Patent · US Active

Synthetic molecule constructs

US10858384B2 · kind B2 · utility

0Cited by

13References

5Claims

0Family size

Assignee

KODE BIOTECH LIMITED · NZ

Inventors

Nicolai Bovin · Moscow, RU
Lissa Gilliver · Auckland, NZ
Stephen Henry · Auckland, NZ
Elena Korchagina · Moscow, RU

Key dates

Filing date	Sep 16, 2019
Grant date	Dec 8, 2020
Priority date	—
Expiry date	Sep 16, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/124
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Synthetic molecule construct of the structure F-S1-S2-L where F-S1 is an aminoalkylglycoside and S2-L is a dicarboxylated, e.g. adipylated, phosphatidylethanolamide are disclosed. The two terminal sugars of the aminoalkylglycoside (Galα1-3Galβ-) are the two terminal sugars of the Galili antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.